Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fowler

Showing results (671-680 of 956) with videos related to

Pageof 96
Sort By:
Human Molecular Genetics|July 17, 2012
Congenital myopathy-causing tropomyosin mutations induce thin filament dysfunction via distinct physiological mechanismsJulien Ochala, David S Gokhin, Isabelle Pénisson-Besnier, et al.
Gynecologic Oncology|January 24, 2016
Survival outcomes of obese patients in type II endometrial cancer: Defining the prognostic impact of increasing BMICaroline C Billingsley, Catherine Cansino, David M O'Malley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology GroupM Markman, B N Bundy, D S Alberts, et al.
American Journal of Hematology|March 28, 2019
MYH9-related disease mutations cause abnormal red blood cell morphology through increased myosin-actin binding at the membraneAlyson S Smith, Kasturi Pal, Roberta B Nowak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patientsCarl Morrison, Vanna Zanagnolo, Nilsa Ramirez, et al.
Blood|October 26, 2013
Tropomodulin3-null mice are embryonic lethal with anemia due to impaired erythroid terminal differentiation in the fetal liverZhenhua Sui, Roberta B Nowak, Andrea Bacconi, et al.
Journal of Cell Science|September 22, 2025
KLF1 coordinates specialized transcriptional networks required to maintain the integrity of terminal erythropoiesisMerlin N Gnanapragasam, Peng Jiang, Anita R Dhara, et al.
Nature Communications|December 9, 2021
Probing ion channel functional architecture and domain recombination compatibility by massively parallel domain insertion profilingWillow Coyote-Maestas, David Nedrud, Antonio Suma, et al.
Gynecologic Oncology|March 1, 1997
A simplified method for detubularization in the construction of a continent ileocolic reservoir (Miami pouch)J A Cosin, J R Carter, P Paley, et al.
Frontiers in Veterinary Science|May 2, 2022
Clinical, Diagnostic, and Imaging Findings in Three Juvenile Dogs With Paraspinal Hyperesthesia or Myelopathy as a Consequence of Hemophilia A: A Case ReportKayla M Fowler, Timothy A Bolton, John H Rossmeisl, et al.
Pageof 96

Showing results (671-680 of 956) with videos related to

Sort By:
Pageof 96
Human Molecular Genetics|July 17, 2012
Congenital myopathy-causing tropomyosin mutations induce thin filament dysfunction via distinct physiological mechanismsJulien Ochala, David S Gokhin, Isabelle Pénisson-Besnier, et al.
Gynecologic Oncology|January 24, 2016
Survival outcomes of obese patients in type II endometrial cancer: Defining the prognostic impact of increasing BMICaroline C Billingsley, Catherine Cansino, David M O'Malley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology GroupM Markman, B N Bundy, D S Alberts, et al.
American Journal of Hematology|March 28, 2019
MYH9-related disease mutations cause abnormal red blood cell morphology through increased myosin-actin binding at the membraneAlyson S Smith, Kasturi Pal, Roberta B Nowak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patientsCarl Morrison, Vanna Zanagnolo, Nilsa Ramirez, et al.
Blood|October 26, 2013
Tropomodulin3-null mice are embryonic lethal with anemia due to impaired erythroid terminal differentiation in the fetal liverZhenhua Sui, Roberta B Nowak, Andrea Bacconi, et al.
Journal of Cell Science|September 22, 2025
KLF1 coordinates specialized transcriptional networks required to maintain the integrity of terminal erythropoiesisMerlin N Gnanapragasam, Peng Jiang, Anita R Dhara, et al.
Nature Communications|December 9, 2021
Probing ion channel functional architecture and domain recombination compatibility by massively parallel domain insertion profilingWillow Coyote-Maestas, David Nedrud, Antonio Suma, et al.
Gynecologic Oncology|March 1, 1997
A simplified method for detubularization in the construction of a continent ileocolic reservoir (Miami pouch)J A Cosin, J R Carter, P Paley, et al.
Frontiers in Veterinary Science|May 2, 2022
Clinical, Diagnostic, and Imaging Findings in Three Juvenile Dogs With Paraspinal Hyperesthesia or Myelopathy as a Consequence of Hemophilia A: A Case ReportKayla M Fowler, Timothy A Bolton, John H Rossmeisl, et al.
Pageof 96